BABY — Else Nutrition Holdings Income Statement
0.000.00%
- CA$5.61m
- CA$6.46m
- CA$7.97m
- 17
- 41
- 34
- 19
Annual income statement for Else Nutrition Holdings, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.48 | 4.69 | 8.53 | 9.36 | 7.97 |
| Cost of Revenue | |||||
| Gross Profit | 0.498 | 0.743 | 1.31 | -0.085 | -1.16 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 10.5 | 22.4 | 29.1 | 26.4 | 22.7 |
| Operating Profit | -9.02 | -17.7 | -20.5 | -17 | -14.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -24.1 | -1.62 | -17.6 | -15.6 | -15.2 |
| Net Income After Taxes | -24.1 | -1.62 | -17.6 | -15.6 | -15.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -24.1 | -1.62 | -17.6 | -15.6 | -15.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.1 | -1.62 | -17.6 | -15.6 | -15.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.296 | -0.017 | -0.162 | -0.134 | -0.091 |